Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2012
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258042 Combined use of tgf-b signaling inhibitor and antitumor agent
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012DE10352433B4 Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle A polypeptide silicatein-ß from Suberites domuncula, nucleic acid coding which uses this vector comprising the nucleic acid and polypeptide expressing this host cell
10/11/2012CA2832735A1 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/11/2012CA2832556A1 Formulations with reduced viscosity
10/11/2012CA2832486A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012CA2832303A1 Pharmaceutical preparation
10/11/2012CA2832130A1 Pharmaceutical composition
10/11/2012CA2831847A1 Sugar and peg functionalized polyacetals with controlled ph-dependent degradation
10/11/2012CA2830372A1 Long-acting peptide analogs
10/10/2012EP2508544A1 Degradable polyacetal polymers
10/10/2012EP2508341A1 Compositions comprising elemental metals and uses therefor
10/10/2012EP2508207A1 Nanoparticles loaded with chemotherapeutic antitumoral Drug
10/10/2012EP2508206A1 Film coating agent for solid preparation, and solid preparation using same
10/10/2012EP2508205A2 Preserved compositions containing hyaluronic acid or a pharmaceutically- acceptable salt thereof and related methods
10/10/2012EP2508187A1 Triflusal powder containing cyclodextrin as a stabilizing agent
10/10/2012EP2508176A1 Novel combination treatment of cancer
10/10/2012EP2508174A1 Pharmaceutical composition
10/10/2012EP2508171A1 Pharmaceutical magnetic nano-particle composition
10/10/2012EP2508169A1 Polymersome and process for producing same
10/10/2012EP2506880A1 Compositions comprising nonsteroidal anti - inflammatory drugs
10/10/2012EP2506879A1 Snalp formulations containing antioxidants
10/10/2012EP2506878A2 Process for preparing pharmaceutical ophthalmic compositions
10/10/2012EP2506868A2 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
10/10/2012EP2506858A1 Starch derivative mixtures
10/10/2012EP2506838A1 Transdermal testosterone device and delivery
10/10/2012EP2506837A2 Spider silk particles for controlled and sustained delivery of compounds
10/10/2012EP2506831A2 Carboxyvinyl polymer-containing nanoparticle suspension
10/10/2012EP2506830A1 Ophthalmic emulsion
10/10/2012EP2263654B1 Compositions for improving the oral absorption of antimicrobial agents
10/10/2012CN1956734B Multi-vitamin and mineral nutritional supplements
10/10/2012CN1956733B Dietary supplement and method of processing same
10/10/2012CN1662251B Adjuvant enhanced immunotherapy
10/10/2012CN1522156B Novel engineered superantigen for human therapy
10/10/2012CN102725002A Agents, uses and methods
10/10/2012CN102725001A Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
10/10/2012CN102724966A Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
10/10/2012CN102724965A Carboxyvinyl polymer-containing nanoparticle suspensions
10/10/2012CN102724961A Topical foam composition
10/10/2012CN102724960A Topical foam composition
10/10/2012CN102718991A High strength injectable hydrogel and preparation method thereof
10/10/2012CN102718977A Heparin sodium-loaded polyurethane micro nanometer particle solution and preparation method and application thereof
10/10/2012CN102718903A Transgenic non-viral vector of guanidinated polyvinyl alcohol, preparation method thereof and application thereof
10/10/2012CN102718868A Fixed point mono-substituted pegylation of Exendin analogue and preparation method thereof
10/10/2012CN102718856A Recombinant chromatin modified albumin 1A, as well as coding gene and application thereof
10/10/2012CN102718254A Mesoporous titanium dioxide and preparation method thereof and application thereof
10/10/2012CN102716500A Cationic macromolecular proteolipid gene medicine carrier, preparation method and application
10/10/2012CN102716497A Alpha1,3 galactosyltransferase-transfected material, its preparation method and application
10/10/2012CN102716496A Clathrate compound of scutellarin and alkaline cyclodextrin and preparation method thereof
10/10/2012CN102716495A Multifunctional poly(malic acid) carried drug for targeting treatment of tumors
10/10/2012CN102716494A Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system
10/10/2012CN102716493A Copolymer containing amorphous agomelatine, and preparation method, pharmaceutical composition and application thereof
10/10/2012CN102716492A Baicalin hydroxypropyl-beta-cyclodextrin inclusion compound as well as preparation method and application thereof
10/10/2012CN102716491A Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same
10/10/2012CN102716490A Method for preparation of pharmaceutical composition having improved disintegradability
10/10/2012CN102716489A Modified starch composition plant capsule and preparation method thereof
10/10/2012CN102716488A Glycyrrhizic acid aureola dimer mediated targeted medication body as well as preparation method and purpose of glycyrrhizic acid aureola dimer mediated targeted medication body
10/10/2012CN102716487A Permeation enhancer for improving transdermal absorption of Ginsenoside-Rd and application thereof
10/10/2012CN102716478A Combined Newcastle disease and infectious bronchitis inactivated vaccine and method for preparing same
10/10/2012CN102716477A Stability of protein in aqueous solution
10/10/2012CN102716469A Dry powder inhalant of interferon alpha
10/10/2012CN102716463A Glycyrrhizic acid organic salt phospholipid ligand and preparation thereof
10/10/2012CN102716171A Compound common andrographis herb taste-masking particles and preparation method thereof
10/10/2012CN102716161A Chinese medicinal ointment for treating scar hyperplasia
10/10/2012CN102716158A In-water type mecamylamine and celery seed oil nanoemulsion antihypertensive medicine
10/10/2012CN102716150A Zinc sulfate syrup oral liquid preparation
10/10/2012CN102716138A Medicinal composition of diammonium glycyrrhizinate sodium chloride
10/10/2012CN102716137A Preparation method and application of fluorescence nanometer diamond-doxycycline compound
10/10/2012CN102716130A Transformable acupoint injection ligustrazine medicine and method for preparing same
10/10/2012CN102716125A Vinpocetine composition and preparation method thereof
10/10/2012CN102716105A Dry powder inhalant of interferon Alpha
10/10/2012CN102716104A Medical organic silicon patch and preparation method thereof
10/10/2012CN102716103A 2, 2', 6, 6'-tetraisopropyl-4, 4'-2-biphenol soft capsule and method for preparing same
10/10/2012CN102716102A Mecobalamin tablet and preparation method thereof
10/10/2012CN102716099A Levocetirizine hydrochloride chewable tablet and preparation method thereof
10/10/2012CN102716098A Cefditoren pivoxil liposome solid preparation
10/10/2012CN102716097A Method for controlling medicament release rate of orally disintegrating tablet
10/10/2012CN102716096A Medicinal composition containing cefotiam hydrochloride
10/10/2012CN102716095A Paclitaxel vesicle type phospholipid gel injection
10/10/2012CN102716092A Formula of aureomycin hydrochloride premix granule and granulating process
10/10/2012CN102716091A Method for preparing metoprolol tartrate particles
10/10/2012CN102716090A Sustained-release metformin hydrochloride pellets and preparation method thereof
10/10/2012CN102716089A Gemcitabine hydrochloride liposome injection
10/10/2012CN102716088A Folate coupled chitosan ligustrazine nanoparticle preparation
10/10/2012CN102716086A Carboxylated polyethylene glycol-polylactic acid segmented copolymer brucine nanoparticles and application thereof
10/10/2012CN102716085A Topotecan hydrochloride liposome injection
10/10/2012CN102716084A Fluoxetine hydrochloride liposome solid preparation
10/10/2012CN102716083A Lafutidine liposome solid preparation and preparing method thereof
10/10/2012CN102716082A Cefoxitin sodium liposome injection
10/10/2012CN102716081A Docetaxel vesicle type phospholipid gel injection
10/10/2012CN102716079A Pirenoxine-containing suspension-type aqueous preparation
10/10/2012CN102716076A Ambroxol hydrochloride medicine combination for injection
10/10/2012CN102716075A Ceftizoxime sodium-containing pharmaceutical composition
10/10/2012CN102716074A Bimatoprost eye drops and preparation method thereof
10/10/2012CN102716073A Medical carboxymethyl chitosan anti-adhesion agent and preparation method thereof
10/10/2012CN102716072A Method for preparing ciprofloxacin lactate sodium chloride injection
10/10/2012CN102716071A Fleroxacin mannitol injection and preparation method thereof
10/10/2012CN102716070A Pinocembrin and cyclodextrin or cyclodextrin derivative clathrate compound
10/10/2012CN102716069A Injection liquid containing ibuprofen and preparation process of injection liquid